EGFR/B3GNT3 pathway-induced PD-L1 glycosylation leads to inhibition of PD-L1 autophagic degradation, subsequently, facilitates tumor immune escape in a breast xenograft tumor model [33]. This evidence concerns the gene EGFR and neoplasm.